↓ Skip to main content
What is this page? Embed badge

PharmVar GeneFocus: CYP2D6

Overview of attention for article published in Clinical Pharmacology & Therapeutics, December 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
1 news outlet
blogs
2 blogs
policy
1 policy source
twitter
9 X users
patent
4 patents
wikipedia
1 Wikipedia page
guideline
3 clinical guideline sources

Readers on

mendeley
201 Mendeley
So far, Altmetric has seen 5 Guidelines that reference this research output.

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker Therapy

Clinical guideline published by Clinical Pharmacogenetics Implementation Consortium (CPIC) on

The Clinical Pharmacogenetics Implementation Consortium (CPIC) is an international group dedicated to enhancing the use of pharmacogenetic testing in clinical settings. They develop and share peer-reviewed, evidence-based guidelines to aid healthcare providers in making informed prescribing decisions based on genetic test results.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants

Clinical guideline published by Clinical Pharmacogenetics Implementation Consortium (CPIC) on

The Clinical Pharmacogenetics Implementation Consortium (CPIC) is an international group dedicated to enhancing the use of pharmacogenetic testing in clinical settings. They develop and share peer-reviewed, evidence-based guidelines to aid healthcare providers in making informed prescribing decisions based on genetic test results.

Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG)

Clinical guideline published by American College of Medical Genetics and Genomics (ACMG) on

The American College of Medical Genetics and Genomics (ACMG) is dedicated to advancing the field of medical genetics through education, advocacy, and the development of clinical practice guidelines. They provide resources such as ACT sheets, algorithms, and educational events to support healthcare professionals in delivering high-quality genetic care.

Recommendations for Clinical CYP2D6 Genotyping Allele Selection A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy

Clinical guideline published by Association for Molecular Pathology (AMP) on

The Association for Molecular Pathology (AMP) serves as a pivotal organization in the molecular diagnostics field, promoting advancements in clinical practice, education, and advocacy. It connects professionals, offers resources, and fosters collaboration to enhance patient care through molecular pathology.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity, including 1 additional posts.